Retinai

Analyzes retinal fundus images to identify and classify stages of diabetic retinopathy using deep learning models trained on extensive retinal imaging datasets. Provides automated detection of microaneurysms, hemorrhages, and exudates characteristic of the disease.

Detects and classifies age-related macular degeneration (AMD) from retinal imaging using specialized AI models. Identifies drusen, geographic atrophy, and neovascular features to stage disease progression.

Provides evidence-based recommendations for clinical management based on detected pathologies, disease severity, and patient risk factors. Suggests appropriate follow-up intervals, treatment options, and specialist referrals.

Processes large volumes of retinal images in batch mode for population-wide screening programs. Enables efficient analysis of hundreds or thousands of images with minimal manual intervention.

Continuously monitors AI model performance in production, comparing predictions against clinician reviews and tracking accuracy metrics. Identifies performance drift and triggers retraining when needed.

Evaluates the technical quality of retinal images and flags those unsuitable for analysis due to poor focus, inadequate field coverage, or artifacts. Reduces manual review burden by automatically filtering out non-diagnostic images.

Centralizes and organizes ophthalmic patient data including imaging, clinical notes, and diagnostic results into a unified patient record. Enables longitudinal tracking of eye health metrics and disease progression across multiple visits.

Automatically compares current retinal images with prior imaging studies to quantify changes in pathology, drusen burden, or other measurable features. Highlights regions of significant change to support disease progression assessment.

Generates structured clinical reports from AI analysis results, including findings, classifications, and recommendations for follow-up. Integrates AI-detected pathologies into standardized report templates for clinician review and signature.

Assigns risk scores to patients based on detected pathologies and disease severity, enabling prioritization of urgent cases for immediate clinician review. Helps triage high-volume screening workloads by flagging cases requiring expedited evaluation.

Analyzes retinal images to detect multiple concurrent pathologies in a single pass, including diabetic retinopathy, AMD, glaucomatous changes, and other retinal conditions. Provides comprehensive assessment of retinal health status.

Integrates AI analysis results directly into existing EHR systems and clinical workflows, enabling seamless data flow from imaging acquisition through diagnosis and treatment planning. Supports HL7/FHIR standards for interoperability.

Tracks quantitative metrics of retinal disease over extended periods, generating trend analyses and progression curves. Enables statistical analysis of disease natural history and treatment response across patient populations.